Gilead Sciences, Inc. 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 4:51 pm Sale |
2021-04-20 | 13G | Allogene Therapeutics, Inc. ALLO |
GILEAD SCIENCES INC GILD |
1,156,689 0.800% |
-6,330,000 (-84.55%) |
Filing |